Clinical Trials Logo

Clinical Trial Summary

The primary goal of the TCD-REDUCE study is to demonstrate the effectiveness of continuous transcranial Doppler sonography ("sonolysis") on the reduction of the ischemic stroke volume during MitraClip implantation.


Clinical Trial Description

Cardiac procedures are associated with new cerebral ischemic lesions detected on diffusion-weighted MRI (Bendszus et al., 2006). A previous study suggests that sonolysis (continuous transcranial Doppler sonography using a 2-MHz diagnostic probe) can reduce the risk of new cerebral ischemic lesions during carotid endarterectomy and carotid angioplasty / stenting (Skoloudik et al., 2015). Currently, it is unknown whether sonolysis can also reduce the risk of new cerebral ischemic lesions during MitraClip implantation - a percutaneous treatment option in patients with moderate / severe mitral regurgitation. In this study, patients will receive cerebral MRI and clinical neurological / neuropsychological examination before and after MitraClip implantation. During MitraClip implantation, all patients will receive continuous transcranial Doppler sonography using a 2-MHz diagnostic probe with maximal diagnostic energy administered through either the left or the right transtemporal window (computer-generated 1:1 randomization). The primary endpoint is the median ischemic lesion volume detected on diffusion-weighted MRI after MitraClip implantation in the sonolysis group and in the control group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04384198
Study type Interventional
Source Charite University, Berlin, Germany
Contact Tim Bastian Braemswig, MD
Phone +49 30 450560624
Email tim-bastian.braemswig@charite.de
Status Recruiting
Phase N/A
Start date August 13, 2020
Completion date December 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03962023 - Prognostic Impact of Imaging Parameters in Patients With Primary Mitral Insufficiency by Prolapse (COHORTE-IM)
Withdrawn NCT02624960 - Safety and Performance of the AccuCinch® System N/A
Terminated NCT02428010 - Twelve Transcatheter Mitral Valve Replacement (TMVR) Pilot Study N/A
Active, not recruiting NCT01533883 - Cardioband Adjustable Annuloplasty System for Minimally Invasive Mitral Valve Repair N/A
Unknown status NCT01201070 - Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Phase 4
Terminated NCT00700947 - Using Beta Blockers to Treat Mitral Regurgitation Phase 1
Completed NCT04351984 - Transcatheter Mitral Valvuloplasty Pilot Study
Completed NCT04231331 - Ertugliflozin for Functional Mitral Regurgitation Phase 3
Completed NCT05742789 - Effect of Anesthetics on Troponin I and ะก-reactive Protein Phase 1
Recruiting NCT02803957 - Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair N/A
Recruiting NCT04153292 - The ENCIRCLE Trial N/A
Completed NCT02607527 - Annular Reshaping of the Mitral Valve for Patients With Mitral Regurgitation Using the Millipede IRIS System N/A
Active, not recruiting NCT03066050 - Long Term Follow Up for CTSN Mitral Valve Repair Studies
Active, not recruiting NCT04443218 - Edwards PASCAL Transcatheter Valve Repair System Registry
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Completed NCT01966146 - Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI N/A
Recruiting NCT01368575 - Surgical Treatment of Ischemic Mitral Regurgitation Phase 4
Completed NCT00001314 - Investigation of Heart Function in Patients With Heart Valve Defects N/A
Terminated NCT03285724 - Safety and Performance Study of the Harpoon Mitral Valve Repair System N/A
Withdrawn NCT04709042 - Acquisition of Objective Data During Transapical Neochordae Implantation N/A